In Vitro Modeling of Natural Killer Cell Cytotoxicity to Inform Personalized ALS Therapeutics is a research paper published in Annals of Clinical and Translational Neurology (2025). On theSindex it has a DataRank of 0.208. It has been cited 3 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.208
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →Agency for Toxic Substances and Disease Registry
Grant: R01TS000339
National Institutes of Health
Grant: R01NS120926
National Institutes of Health
Grant: R01NS127188
U.S. Department of Defense
Grant: AL200064
ALS Association
Grant: 20‐IIA‐431
ALS Association
Grant: 20-IIA-431
Robert A. Epstein and Joan M. Chernoff-Epstein Emerging Scholar Fund
NeuroNetwork for Emerging Therapies at the University of Michigan
Coleman Discovery Fund
Peter R. Clark Fund for ALS Research
Sinai Medical Staff Foundation
Hiller and Novak Families
Scott L. Pranger
Peter R. Clark Fund for ALS Research
Coleman Discovery Fund
Scott L. Pranger
Robert A. Epstein and Joan M. Chernoff-Epstein Emerging Scholar Fund
Sinai Medical Staff Foundation
Hiller and Novak Families
NeuroNetwork for Emerging Therapies at the University of Michigan
FWCI
2.15
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals